Related Experiment Video
Updated: Dec 5, 2025
09:58
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
3.0K
[Advancement of E2F1 in Common Tumors]
Cheng Shen1, Jue Li1, Shuai Chang1
1Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|October 18, 2020
Summary
Transcription factor E2F1, crucial for cell cycle, is highly expressed in tumors and promotes cancer. Targeting E2F1 offers a promising new strategy for effective cancer treatment and therapy.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- E2F1 is a transcription factor regulating key cellular processes like cell cycle progression, DNA repair, and apoptosis.
- E2F1 is frequently overexpressed in various cancer types, acting as an oncogene.
- Its elevated expression correlates with tumor initiation, progression, metastasis, and poor prognosis.
Purpose of the Study:
- To review the recent advancements in understanding the role of E2F1 in common human tumors.
- To highlight E2F1 as a potential therapeutic target for cancer treatment.
Main Methods:
- Literature review of current research on E2F1 in oncology.
- Analysis of studies investigating E2F1 expression and its correlation with tumor characteristics.
- Synthesis of findings regarding E2F1's oncogenic functions.
Main Results:
- E2F1 plays a significant role in promoting tumor growth and metastasis across various cancers.
- Up-regulation of E2F1 is a common event in tumorigenesis.
- E2F1's involvement in critical cellular pathways makes it a key player in cancer development.
Conclusions:
- E2F1 is a critical oncogene with a multifaceted role in cancer progression.
- Targeting E2F1 presents a promising avenue for novel cancer therapies.
- Further research into E2F1's mechanisms could lead to improved cancer treatment strategies.
Related Concept Videos
01:20The Retinoblastoma Gene
4.5K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.5K
02:38Mitogens and the Cell Cycle
7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
02:07Tumor Progression
7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
03:03mTOR Signaling and Cancer Progression
4.4K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K